News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ViRexx Medical Corp. (VIR.V) Announces 2008 Second Quarter Results


8/14/2008 11:39:22 AM

EDMONTON, ALBERTA--(Marketwire - August 14, 2008) - ViRexx Medical Corp. (TSX: VIR) (AMEX: REX), company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living. Its platform technologies include product candidates for the treatment of Hepatitis B, Hepatitis C, avian influenza viral infections, biodefence and nanoparticle applications, select solid tumors and late-stage ovarian cancer, today announced its financial and operational results for the three-month period ended June 30, 2008.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES